Cargando…
Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
BACKGROUND: Studies of Alzheimer’s disease suggest that neuroinflammation or deranged brain wound healing may be a cause of some cases. But a placebo controlled study showed no effect at all on Alzheimer’s disease of low dose oral prednisone after one year. Introducing the steroid directly into the...
Autores principales: | Lehrer, Steven, Rheinstein, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110392/ https://www.ncbi.nlm.nih.gov/pubmed/30159547 http://dx.doi.org/10.3233/ADR-170033 |
Ejemplares similares
-
No Relationship of Anti-Androgens to Alzheimer’s Disease or Cognitive Disorder in the MedWatch Database
por: Lehrer, Steven, et al.
Publicado: (2018) -
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019) -
Beyond post-marketing research and MedWatch: Long-term studies of
drug risks
por: Resnik, David B
Publicado: (2007) -
Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents
por: Davis, Kourtney J., et al.
Publicado: (2016) -
Lost in the Mist: Acute Adrenal Crisis Following Intranasal Fluticasone Propionate Overuse
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2010)